OTCMKTS:PPCB

Propanc Biopharma Stock Insider Trading

etoro logo Buy PPCB
*Your capital is at risk
$1.64
-0.135 (-7.63%)
At Close: Jun 03, 2026

Propanc Biopharma Stock Insider Power

Based on the 48 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 560.62M and sold 661K PPCB shares in the last 48 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 48 transactions)
0
Buy 560.62M shares
Sell 661K shares
79% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 05, 2023
Buy
Common Stock Purchase Warrant
A-Award
Zelinger Josef
Director
Director 15 000 000
Value: $150.0K
Jul 05, 2023
Buy
Common Stock Purchase Warrant
A-Award
Zelinger Josef
Director
Director 15 000 000
Value: $150.0K
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Nathanielsz James Andrew
CEO/cfo
CEO / President 5 928 000
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Nathanielsz James Andrew
CEO/cfo
CEO / President 2 800 000
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
Zelinger Josef
Director
Director 0
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
Zelinger Josef
Director
Director 0
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Nathanielsz James Andrew
CEO/cfo
CEO / President 2 800 000
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Nathanielsz James Andrew
CEO/cfo
CEO / President 5 928 000
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 3 420 000
Value: $0
Aug 17, 2021
Buy
Common stock, par value $0.001
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 3 420 000
Value: $0
Jun 24, 2019
Buy
Common Stock
J-Other
Campiciano Carlo M
Officer
Officer 0
Value: $0
Jun 24, 2019
Buy
Common Stock
J-Other
Campiciano Carlo M
Officer
Officer 0
Value: $0
May 14, 2019
Buy
Restricted Stock Units
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 9 750 000
Value: $0
May 14, 2019
Buy
Stock Options (Right to Buy)
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 9 750 000
Value: $82.9K
May 14, 2019
Buy
Stock Options (Right to Buy)
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 9 750 000
Value: $82.9K
May 14, 2019
Buy
Restricted Stock Units
A-Award
Kenyon Julian Norman
Chief Scientific Officer
Officer 9 750 000
Value: $0
May 14, 2019
Buy
Restricted Stock Units
A-Award
Nathanielsz James Andrew
CEO, Acting CFO, Chairman
CEO / President 19 500 000
Value: $0
May 14, 2019
Buy
Stock Options (Right to Buy)
A-Award
Nathanielsz James Andrew
CEO, Acting CFO, Chairman
CEO / President 19 500 000
Value: $183.3K
May 14, 2019
Buy
Stock Options (Right to Buy)
A-Award
Nathanielsz James Andrew
CEO, Acting CFO, Chairman
CEO / President 19 500 000
Value: $183.3K
May 14, 2019
Buy
Restricted Stock Units
A-Award
Nathanielsz James Andrew
CEO, Acting CFO, Chairman
CEO / President 19 500 000
Value: $0
Apr 14, 2016
Buy
Stock Option (Right to Buy)
A-Award
Nathanielsz James Andrew
CEO, CFO, Secretary, Treasurer
CEO / President 71 500 000
Value: $2.15M
Apr 14, 2016
Buy
Stock Option (Right to Buy)
A-Award
Kenyon Julian Norman
Director
Director 71 500 000
Value: $2.15M
Apr 14, 2016
Buy
Stock Option (Right to Buy)
A-Award
Nathanielsz James Andrew
CEO, CFO, Secretary, Treasurer
CEO / President 71 500 000
Value: $2.15M
Apr 14, 2016
Buy
Stock Option (Right to Buy)
A-Award
Kenyon Julian Norman
Director
Director 71 500 000
Value: $2.15M
Feb 04, 2015
Buy
Common Stock, par value $0.001
J-Other
Kenyon Julian Norman
Director
Director 17 654 470
Value: $311.7B

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PROPANC BIOPHARMA INC
Propanc Biopharma
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE